Drug Shortage Report for DIOVAN 160MG TABLETS

Last updated on 2020-03-20 History
Report ID 103181
Drug Identification Number 02244782
Brand name DIOVAN 160MG TABLETS
Common or Proper name DIOVAN FCT 160MG 2X14
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) VALSARTAN
Strength(s) 160MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 2 X 14
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-01-09
Estimated end date 2020-03-16
Actual end date 2020-03-19
Shortage status Resolved
Updated date 2020-03-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-13 English Compare
v2 2020-01-13 French Compare
v3 2020-01-28 English Compare
v4 2020-01-28 French Compare
v5 2020-02-04 English Compare
v6 2020-02-04 French Compare
v7 2020-02-20 English Compare
v8 2020-02-20 French Compare
v9 2020-02-28 English Compare
v10 2020-02-28 French Compare
v11 2020-03-09 English Compare
v12 2020-03-09 French Compare
v13 2020-03-20 English Compare
v14 2020-03-20 French Compare

Showing 1 to 14 of 14